Skip to main content

and
  1. Article

    Open Access

    Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma

    Recently, a phase II clinical trial in hepatocellular carcinoma (HCC) has suggested that the combination of sorafenib and 5-fluorouracil (5-FU) is feasible and side effects are manageable. However, preclinical...

    Lifen Deng, Zhenggang Ren, Qingan Jia, Weizhong Wu, Hujia Shen, Yanhong Wang in BMC Cancer (2013)

  2. Article

    Open Access

    Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells

    Aberrant activity of tyrosine-phosphorylated proteins is commonly associated with HCC metastasis. Cell signaling events driven by these proteins are implicated in numerous processes that alter cancer cell beha...

    Haiyu Li, Zhenggang Ren, **aonan Kang, Lan Zhang, Xuefei Li, Yan Wang in BMC Cancer (2009)